Physician profile
Jane E Rudolph
NPI 1649266339
$3,624.33
in general payments reported to CMS, 2019-2025
31 companies · $746 in 2025
The $746 reported for 2025 was more than what 88% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $696 · 2020: $216 · 2021: $560 · 2022: $719 · 2023: $231 · 2024: $456 · 2025: $746.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,414 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,414.34 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $666.38 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $316.60 | 2021-2025 | |
| Coopersurgical, INC. | $261.87 | 2021-2025 | Paragard T 380a |
| Biogen, INC. | $246.01 | 2024-2025 | Zurzuvae |
| Myovant Sciences INC. | $240.87 | 2021-2022 | |
| Therapeuticsmd, INC. | $218.96 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $208.37 | 2022-2024 | |
| Exeltis, USA INC. | $167.76 | 2019-2025 | Slynd |
| Novo Nordisk INC | $155.76 | 2022-2025 | Wegovy |
| Medicem INC. | $138.07 | 2021-2022 | |
| Amag Pharmaceuticals, INC. | $133.79 | 2019 | |
| Baxter Healthcare | $123.12 | 2025 | Perclot |
| Organon LLC | $93.17 | 2025 | Jada System |
| Radiometer America, INC | $80.58 | 2024 | |
| Avion Pharmaceuticals | $76.00 | 2019-2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $75.36 | 2025 | Veozah |
| Pfizer INC. | $68.55 | 2021-2023 | |
| Duchesnay USA Incorporated | $58.64 | 2019 | |
| Mallinckrodt Enterprises LLC | $47.50 | 2019 | |
| Hologic Sales and Service, LLC | $41.10 | 2023-2025 | Myosure Tissue Removal Device, Thinprep 2000 Processor, Aptima |
| Mission Pharmacal Company | $33.16 | 2022 | |
| Amgen INC. | $30.59 | 2019-2023 | Prolia, Evenity |
| Sumitomo Pharma America, INC. | $22.06 | 2023 | Myfembree |
| Smith+Nephew, INC. | $19.67 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $18.11 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.89 | 2020 | |
| Aspira Women'S Health INC | $14.42 | 2020 | |
| Glaxosmithkline, LLC. | $14.10 | 2019 | |
| Allergan, INC. | $13.74 | 2020 | |
| Agile Therapeutics, INC. | $12.83 | 2021 | |
| Avanos Medical | $11.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Rudolph listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.